Brief: Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement
08/05/2025 23:24
IGM Biosciences Inc IGMS.O: IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS Source text: [ID:n0001193125-25-116071] Further company coverage: IGMS.O
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary